Drug Regulatory Pathways (A TR Talk)

Successfully bringing a drug to market takes years of effort and billions of dollars.

The immediacy of the current pandemic has researchers investigating repurposing existing medications to expedite the path to successful treatments.

Regardless of the approach, the progression of a drug to market requires evidence and the ability to navigate regulations and associated administrative requirements.

This TR Talks brings together a panel of experts to share their experiences from the front lines of clinical trials. Their failures, successes, and everything they learned along the way.

Interested in translational research? Find out more about our masters program.

Special Guests

Ruth Ross
CAMH
Senior Scientist, Campbell Family Mental Health Research Institute

Paul Grootendorst
University of Toronto
Director of the Division of Social and Administrative Pharmacy

Ayman Chit
University of Toronto
Drug Development and Disease Diagnostics Health Services Research